Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005289065 | SCV005952232 | uncertain significance | Inborn genetic diseases | 2025-01-23 | criteria provided, single submitter | clinical testing | The c.1853C>A (p.A618D) alteration is located in exon 11 (coding exon 10) of the TAP2 gene. This alteration results from a C to A substitution at nucleotide position 1853, causing the alanine (A) at amino acid position 618 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |